Feasibility of Outpatient Follow-Up After High-Dose Cytarabine Consolidation in Patients With Acute Myeloid Leukemia.

Ullah MF, Kibria MG, Rahman KF, Hossen MZ, Sultana N, Kabir AL, Biswas AR.

Open source

DOI
10.7759/cureus.106502
Published
2026-04-06
Container
Cureus
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.7759/cureus.106502,
  title = {Feasibility of Outpatient Follow-Up After High-Dose Cytarabine Consolidation in Patients With Acute Myeloid Leukemia.},
  author = {Ullah MF and  Kibria MG and  Rahman KF and  Hossen MZ and  Sultana N and  Kabir AL and  Biswas AR.},
  year = {2026},
  journal = {Cureus},
  doi = {10.7759/cureus.106502},
  url = {https://doi.org/10.7759/cureus.106502}
}

RIS

TY  - JOUR
TI  - Feasibility of Outpatient Follow-Up After High-Dose Cytarabine Consolidation in Patients With Acute Myeloid Leukemia.
AU  - Ullah MF
AU  -  Kibria MG
AU  -  Rahman KF
AU  -  Hossen MZ
AU  -  Sultana N
AU  -  Kabir AL
AU  -  Biswas AR.
PY  - 2026
JO  - Cureus
DO  - 10.7759/cureus.106502
UR  - https://doi.org/10.7759/cureus.106502
ER  - 

APA

MF, U., MG, K., KF, R., MZ, H., N, S., AL, K., & AR., B. (2026). Feasibility of Outpatient Follow-Up After High-Dose Cytarabine Consolidation in Patients With Acute Myeloid Leukemia.. Cureus. https://doi.org/10.7759/cureus.106502

Source records